- Home
- CRDL vs VOXR Comparison
CRDL vs VOXR Comparison
Compare CRDL & VOXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- VOXR
- Stock Information
- Founded
- CRDL 2017
- VOXR 2014
- Country
- CRDL Canada
- VOXR Canada
- Employees
- CRDL N/A
- VOXR N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- VOXR Precious Metals
- Sector
- CRDL Health Care
- VOXR Basic Materials
- Exchange
- CRDL Nasdaq
- VOXR Nasdaq
- Market Cap
- CRDL 125.7M
- VOXR 125.5M
- IPO Year
- CRDL N/A
- VOXR N/A
- Fundamental
- Price
- CRDL $1.28
- VOXR $2.35
- Analyst Decision
- CRDL Strong Buy
- VOXR
- Analyst Count
- CRDL 3
- VOXR 0
- Target Price
- CRDL $9.00
- VOXR N/A
- AVG Volume (30 Days)
- CRDL 391.0K
- VOXR 137.4K
- Earning Date
- CRDL 11-14-2024
- VOXR 11-06-2024
- Dividend Yield
- CRDL N/A
- VOXR 2.04%
- EPS Growth
- CRDL N/A
- VOXR N/A
- EPS
- CRDL N/A
- VOXR N/A
- Revenue
- CRDL N/A
- VOXR $11,147,864.00
- Revenue This Year
- CRDL N/A
- VOXR N/A
- Revenue Next Year
- CRDL N/A
- VOXR $9.70
- P/E Ratio
- CRDL N/A
- VOXR N/A
- Revenue Growth
- CRDL N/A
- VOXR N/A
- 52 Week Low
- CRDL $0.79
- VOXR $1.70
- 52 Week High
- CRDL $3.12
- VOXR $3.24
- Technical
- Relative Strength Index (RSI)
- CRDL 26.78
- VOXR 33.88
- Support Level
- CRDL $1.27
- VOXR $2.24
- Resistance Level
- CRDL $1.46
- VOXR $2.72
- Average True Range (ATR)
- CRDL 0.10
- VOXR 0.10
- MACD
- CRDL -0.00
- VOXR -0.02
- Stochastic Oscillator
- CRDL 3.33
- VOXR 23.16
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About VOXR Vox Royalty Corp.
Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of over 60 royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector.